Exchange: NASDAQ·Updated 08:25 AM EDT
About QCLS
Q/C Technologies, Inc. engages in the provision of energy-efficient blockchain and cryptocurrency infrastructure through quantum-class laser-based computing. It operates through the Pharmaceuticals and Computing Technology segments. The Pharmaceuticals segment operates in the clinical-stage pharmaceutical space and is specifically focused on isomyosamine (formerly MYMD-1). The Computing Technology segment is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications and beyond. The company was founded in 1989 and is headquartered in New York, NY.